Age-related reference intervals for bone turnover markers from an Australian reference population

Bone

Volumn 55, Issue 2, 2013, Pages 271-276

  Jenkins, N ^a   Black, M ^a   Paul, E ^b   Pasco, J A ^c,d   Kotowicz, M A ^c,d   Schneider, H G ^a,b  

^a Alfred Pathology Service   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Bone turnover marker; CTx; P1NP; Reference interval

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; PROCOLLAGEN TYPE 1 AMINOPROPEPTIDE; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; AUSTRALIA; BONE GROWTH; BONE TURNOVER; CONTROLLED STUDY; FEMALE; HUMAN; LABORATORY DEVICE; MALE; REFERENCE VALUE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AUSTRALIA; COLLAGEN TYPE I; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PEPTIDES; PROCOLLAGEN; REFERENCE VALUES; YOUNG ADULT;

EID: 84877791650     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.04.003     Document Type: Article

References (41)

1. Henry M.J., Pasco J.A., Nicholson G.C., Kotowicz M.A. Prevalence of osteoporosis in Australian men and women: Geelong Osteoporosis Study. Med J Aust 2011, 195(6):321-322.
2. Stepan J.J. Prediction of bone loss in premenopausal women. Osteoporos Int 2000, 11(Suppl. 6):S45-S54.
3. Bauer D.C., Garnero P., Harrison S.L., Cauley J.A., Eastell R., Ensrud K.E., et al. Biochemical markers of bone turnover, hip bone loss and fracture in older men: the MrOs study. J Bone Miner Res 2009, 24:2032-2038.
4. Garnero P., Sornay-Rendu E., Clausatrat B., Delmas P.D. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 2000, 15:1526-1536.
5. Ross P.D., Kress B.C., Parson R.E., Wasnich R.D., Armour K.A., Mizrahi I.A. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study. Osteoporos Int 2000, 11:76-82.
6. Sornay-Rendu E., Munoz F., Garnero P., Duboeuf F., Delmas P.D. Identification of osteopenic women at high risk of fracture: the OFELY study. J Bone Miner Res 2005, 20:1813-1819.
7. Vasikaran S., Eastell R., Bruyere O., Foldes A.J., Garnero P., Griesmacher A., et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 2011, 22:391-420.
8. Dempster D.W., Zhou H., Recker R.R., Brown J.P., Bolognese M.A., Recknor C.P., et al. Skeletal histomorphometry in subjects on teriparatide or zoledronic acid therapy (SHOTZ) study: a randomised controlled trial. J Clin Endocrinol Metab 2012, 97(8):2799-2808.
9. Recker R.R., Marin F., Ish-Shalom S., Moricke R., Hawkins F., Kapetanos G., et al. Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis. J Bone Miner Res 2009, 24(8):1358-1386.
10. Chen J.S., Cameron I.A., Cumming R.C., Lord S.R., March L.M., Sambrook P.N., et al. Effect of age-related chronic immobility on markers of bone turnover. J Bone Miner Res 2006, 21:324-331.
11. de Papp A.E., Bone H.G., Caulfield M.P., Kagan R., Buinewicz A., Chen E., et al. A cross-sectional study of bone turnover markers in healthy premenopausal women. Bone 2007, 40:1222-1230.
12. Glover S.J., Garnero P., Naylor K., Rogers A., Eastell R. Establishing a reference range for bone turnover markers in young, healthy women. Bone 2008, 42:623-630.
13. Glover S.J., Gall M., Schoenborn-Kellenberger O., Wagener M., Garnero P., Boonen S., et al. Establishing a reference interval for bone turnover markers in 637 healthy, young, pre-menopausal women from UK, France, Belgium and the USA. J Bone Miner Res 2009, 24:389-397.
14. Martinez J., Olmos J., Hernandez J.L., Pinedo G., Llora J., Obregon E., et al. Bone turnover markers in Spanish postmenopausal women the Camargo cohort study. Clin Chim Acta 2009, 409:70-74.
15. Lenora J., Ivaska K.K., Obrant K.J., Gerhem P. Prediction of bone loss using biochemical markers of bone turnover. Osteoporos Int 2007, 18(9):1297-1305.
16. Pasco J.A., Nicholson G.C., Kotowicz M.A. Cohort profile: Geelong Osteoporosis Study. Int J Epidemiol 2012, 41(6):1565-1575.
17. Olmos J.M., Hernandez J.L., Martinez J., Pariente E., Llorca J., Gonsalvez-Macias J. Bone turnover markers in Spanish adult men the Camargo cohort study. Clin Chim Acta 2010, 411:1511-1515.
18. Roche Diagnostics (2007-07) β-Crosslaps/serum [package insert]. Manneheim, Germany.
19. Kunchur R., Need A., Hughes T., Goss A. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. J Oral Maxillfax Surg 2009, 67(6):1167-1173.
20. Dos Reis L.M., Batalha J.R., Munoz D.R., Borelli A., Correa P.H.S., Carvalho A.B., et al. Brazilian normal static bone histomorphometry: effects of age, sex and race. J Bone Miner Metab 2007, 25:400-406.
21. Rehman M.T.A., Hoyland J.A., Denton J., Freemont A.J. Age related histomorphometric changes in bone in normal British men and women. J Clin Pathol 1994, 47:529-534.
22. Wishart J.M., Need A.G., Horowitz M., Morris H.A., Nordin B.E.C. Effect of age on bone density and bone turnover in men. Clin Endocrinol 1995, 42:141-145.
23. Fatayeri D., Eastell R. Age-related changes in bone turnover in men. J Bone Miner Res 1999, 14:1203-1210.
24. Szulc P., Garnero P., Munoz F., Marchand F., Delmas P.D. Cross-sectional evaluation of bone metabolism in men. J Bone Miner Res 2001, 16:1642-1650.
25. Recker R.R., Kimmel D.B., Parfitt M., Davies M., Keshawarz N., Hinders S. Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females. J Bone Miner Res 1998, 3:133-143.
26. Hassager C., Risteli J., Risteli L., Christiansen C. Effect of the menopause and hormone replacement therapy on the carboxyl-terminal pyridinoline cross-linked telopeptide of the type I collagen. Osteoporos Int 1994, 4:349-352.
27. Midtby M., Magnus J.H., Joakimsen R.M. The Tromso study: a population-based study on the variation in bone formation markers with age, gender, anthropometry and season in both men and women. Osteoporos Int 2001, 12:835-843.
28. Sgherzi M., Fabbri G., Bonati M., Maietta Latessa A., Segre A., De Vita D., et al. Episodic changes of serum procollagen type I carboxy-terminal propeptide levels in fertile and postmenopausal women. Gynecol Obstet Invest 1994, 38:60-64.
29. Garnero P., Sornay-Rendu E., Chapuy M.C., Delmas P.D. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996, 11:337-349.
30. Qvist P., Christgau P., Pedersen B.J., Schlemmer A., Christiansen C. Circadian variation in the serum concentration of C-terminal telopeptides of type I collagen (serum CTX): effects of gender, age, menopausal status, posture, daylight, serum cortisol and fasting. Bone 2002, 31:57-61.
31. Pedersen B.J., Schlemmer A., Rosenquist C., Hassager C., Christiansen C. Circadian rhythm in type I collagen formation in post menopausal women with and without osteopenia. Osteoporosis Int 1995, 5:472-477.
32. Hassager C., Risteli J., Risteli L., Jensen S.B., Christiansen C. Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women. J Bone Miner Res 1992, 7:1307-1311.
33. Pasco J.A., Henry M.J., Kotowicz M.A., Sanders K.M., Seeman E., Pasco J.R., et al. Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study. J Bone Miner Res 2004, 19(5):752-758.
34. Woitge H.W., Knothe A., Witte K., Schmidt-Gayk H., Ziegler R., Lemmer B., et al. Circannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: a prospective study. J Bone Miner Res 2000, 15:2443-2450.
35. Krolner B. Seasonal variation of lumbar spine bone mineral content in normal women. Calcif Tissue Int 1983, 35:145-147.
36. Blumsohn A., Naylor K.E., Timm W., Eagleton A.C., Hannon R.A., Eastell R. Absence of marked seasonal change in bone turnover: a longitudinal and multicenter cross-sectional study. J Bone Miner Res 2003, 18:1274-1281.
37. Patel R., Collins D., Bullock S., Swaminathan R., Blake G.M., Fogelman I. The effect of season and vitamin D supplementation on bone mineral density in healthy women: a double-masked crossover study. Osteoporos Int 2001, 12:319-325.
38. Qvist P., Munk M., Hoyle N., Christiansen C. Serum and plasma fragments of C-telopeptides of type I collagen (CTX) are stable during storage at low temperatures for 3years. Clin Chim Acta 2004, 350(1-2):167-173.
39. Siebel M.J. Biochemical markers of bone turnover part I: biochemistry and variability. Clin Biochem Rev 2005, 26(4):97-122.
40. Stokes F.J., Ivanov P., Bailey L.M., Fraser W.D. The effects of sampling procedures and storage conditions on short-term stability of blood-based biochemical markers of bone metabolism. Clin Chem 2011, 57:138-140.
41. Oremek G., Sauer-Eppel H., Klepzig M. Total procollagen type 1 amino-terminal propeptide (total P1NP) as a bone metastasis marker in gynaecological carcinomas. Anticancer Res 2007, 27:1961-1962.